Search

Cogent Biosciences Inc

Fechado

31.36 -5.51

Visão Geral

Variação de preço das ações

24h

Atual

Mín

31.36

Máximo

31.94

Indicadores-chave

By Trading Economics

Rendimento

947K

-96M

EPS

-0.52

Funcionários

258

EBITDA

537K

-94M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+76.72% upside

Dividendos

By Acuity

Próximos Ganhos

2 de nov. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-842M

5.8B

Abertura anterior

36.87

Fecho anterior

31.36

Cogent Biosciences Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

20 de set. de 2026, 23:51 UTC

BoJ Meeting Minutes on September 27 Expected to Influence Japan's Interest Rate Outlook Amid Global Economic Uncertainties.

20 de set. de 2026, 23:11 UTC

PBOC Holds Loan Prime Rate Steady at 3.00% Amid Economic Caution and Mixed Signals in China

20 de set. de 2026, 23:01 UTC

Macro News
Correlated Moves

The Dow Jones Index is advancing as the People's Bank of China maintains its Loan Prime Rates amid cautious market conditions and geopolitical tensions.

20 de set. de 2026, 23:01 UTC

Correlated Moves
Macro News

The S&P 500 Index is advancing amid macroeconomic developments, including China's unchanged Loan Prime Rates and mixed industrial production and retail sales data.

20 de set. de 2026, 23:01 UTC

Macro News
Correlated Moves

The Nasdaq 100 Index is advancing, supported by the Russell 2000's rise and the People's Bank of China's decision to maintain its Loan Prime Rate at 3.00%.

20 de set. de 2026, 23:01 UTC

Correlated Moves
Macro News

The Russell 2000 Index is modestly higher, reflecting a stable market backdrop amid China's unchanged Loan Prime Rate and geopolitical tensions.

20 de set. de 2026, 23:00 UTC

Macro News

Oil (WTI) is advancing amid heightened geopolitical tensions following Houthi attacks in Saudi Arabia and ongoing U.S. energy policy discussions, despite earlier session pullbacks.

20 de set. de 2026, 23:00 UTC

The EUR/NOK is declining as trading resumes for the week, influenced by ongoing geopolitical tensions in the Middle East and U.S.-Iran relations.

20 de set. de 2026, 23:00 UTC

The EUR/CHF is slightly lower in early trading this week, reflecting routine fluctuations amid ongoing geopolitical tensions, particularly in the Middle East.

20 de set. de 2026, 23:00 UTC

The EUR/CZK is slightly lower as trading resumes for the week, reflecting geopolitical tensions affecting financial markets despite remaining near the upper end of its one-month range.

20 de set. de 2026, 23:00 UTC

Avalanche is experiencing a sharp increase in value, maintaining a position well above its 20-day moving average amid ongoing geopolitical tensions.

20 de set. de 2026, 22:51 UTC

U.S. 30-Year Mortgage Rate Hits Highest Level Since May at 6.97%, Sparking Concerns Over Housing Demand Amid Rising Treasury Yields and Inflation Fears

20 de set. de 2026, 22:51 UTC

Chicago Fed National Activity Index Release on September 21, 2026, Anticipates Continued Economic Uncertainty Amid Recent Volatility.

20 de set. de 2026, 22:11 UTC

UK Consumer Confidence Index Set for Release Amid Mixed Sentiment and Economic Concerns, Forecast at -16.0

20 de set. de 2026, 22:01 UTC

Correlated Moves

The AUD/USD is slightly lower in early trading, reflecting a cautious investor outlook amid ongoing Middle East conflict and recent interest rate hikes.

20 de set. de 2026, 22:00 UTC

The EUR/PLN is advancing in early trading, reflecting a notable increase since Friday's close amid ongoing geopolitical tensions and central bank interest rate hikes.

20 de set. de 2026, 21:21 UTC

Australia's S&P Global Manufacturing PMI Flash set for September 22, with cautious optimism amid global economic pressures.

20 de set. de 2026, 21:21 UTC

Australia's S&P Global Services PMI Flash set for September 22, with cautious optimism amid global market influences.

20 de set. de 2026, 21:01 UTC

Brazil's Central Bank to Release Key Market Readout on Interest Rates and Economic Forecasts on September 21, 2026.

20 de set. de 2026, 20:51 UTC

UK CBI Distributive Trades Forecasts Sharp Decline in Retail Sales Sentiment at -50.0 Amid Ongoing Consumer Spending Downturn

20 de set. de 2026, 20:21 UTC

UK Factory Orders Show Resilience with Improved Order Book Balance, Yet Forecasts Indicate Continued Decline Amid Economic Challenges.

20 de set. de 2026, 20:21 UTC

API Crude Oil Stock Change Report on September 22, 2026, Expected to Reveal Rising U.S. Inventories Amid Geopolitical Tensions Impacting Market Sentiment.

20 de set. de 2026, 19:21 UTC

South Korea's Consumer Confidence Index Release on September 22 Expected to Reflect Cautious Optimism Amid Economic Volatility.

20 de set. de 2026, 18:51 UTC

Germany's Ifo Business Climate Index set to release with a forecast of 89.2, reflecting cautious optimism amid geopolitical tensions and inflationary pressures.

20 de set. de 2026, 18:51 UTC

South Africa's Inflation Rate MoM Release on September 23, 2026 Expected to Reflect Global Economic Trends Amid Rising Concerns.

20 de set. de 2026, 18:51 UTC

South Africa's Inflation Rate Release on September 23, 2026, Expected to Reflect Economic Pressures Amid Rising Costs and Geopolitical Tensions.

20 de set. de 2026, 18:41 UTC

Cautious Optimism for Euro Area Manufacturing as S&P Global PMI Flash Set to Show Growth at 52.9 Amid Geopolitical Challenges

20 de set. de 2026, 18:41 UTC

Spain's Balance of Trade Data Set for Release Amidst Ongoing Trade Deficits and Rising Import Costs, Raising Inflation Concerns in the Eurozone.

20 de set. de 2026, 18:41 UTC

Swiss National Bank Expected to Maintain Zero Interest Rate Amid Subdued Inflation and Modest Economic Growth

20 de set. de 2026, 18:41 UTC

French Services PMI Flash Expected at 48.5 Amid Political and Economic Concerns, Signaling Continued Contraction

Comparação entre Pares

Variação de preço

Cogent Biosciences Inc Previsão

Preço-alvo

By TipRanks

76.72% parte superior

Previsão para 12 meses

Média 55.667 USD  76.72%

Máximo 62 USD

Mínimo 52 USD

Com base em 7 analistas de Wall Street que oferecem metas de preço de 12 meses para Cogent Biosciences Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

7 ratings

6

Comprar

1

Manter

0

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Cogent Biosciences Inc

Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor designed to target mutations within the KIT receptor tyrosine kinase, including KIT D816V KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. The company has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.